VivoSim Labs, Inc.
VIVS
$2.11
$0.136.57%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 142.00K | 144.00K | 122.00K | 103.00K | 73.00K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 142.00K | 144.00K | 122.00K | 103.00K | 73.00K |
| Cost of Revenue | 3.64M | 3.65M | 3.86M | 3.51M | 3.86M |
| Gross Profit | -3.50M | -3.51M | -3.74M | -3.41M | -3.79M |
| SG&A Expenses | 7.66M | 7.73M | 7.45M | 7.99M | 9.11M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 12.29M | 12.76M | 12.68M | 12.87M | 14.35M |
| Operating Income | -12.15M | -12.62M | -12.56M | -12.77M | -14.28M |
| Income Before Tax | -1.99M | -2.49M | -12.38M | -12.54M | -13.99M |
| Income Tax Expenses | 0.00 | 2.00K | 2.00K | 2.00K | 2.00K |
| Earnings from Continuing Operations | -1.99 | -2.49 | -12.39 | -12.54 | -13.99 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1.99M | -2.49M | -12.39M | -12.54M | -13.99M |
| EBIT | -12.15M | -12.62M | -12.56M | -12.77M | -14.28M |
| EBITDA | -11.89M | -12.35M | -12.28M | -12.49M | -13.99M |
| EPS Basic | -1.25 | -2.85 | -10.70 | -13.36 | -17.48 |
| Normalized Basic EPS | -4.62 | -5.62 | -6.69 | -8.35 | -10.92 |
| EPS Diluted | -1.25 | -2.85 | -10.70 | -13.36 | -17.48 |
| Normalized Diluted EPS | -4.62 | -5.62 | -6.69 | -8.35 | -10.92 |
| Average Basic Shares Outstanding | 43.19M | 41.90M | 41.11M | 31.43M | 21.38M |
| Average Diluted Shares Outstanding | 43.19M | 41.90M | 41.11M | 31.43M | 21.38M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |